A 37-year-old volunteer named Ed Hunt received the first dose of an experimental vaccine targeting the Bundibugyo Ebola strain at Oxford University on Friday — just eight weeks after researchers began work on it. The shot, ChAdOx1 BDBV, uses the same viral-vector technology that powered AstraZeneca's COVID-19 vaccine. "We've taken this vaccine candidate from concept to clinic in just eight weeks," said David Pulido-Gomez of Oxford's Pandemic Sciences Institute....